Skip to main content

Table 3 Network meta-analysis of cytokines levels in COVID-19 patients with different clinical stages MD (95%CI)

From: Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis

Comparisons

IL-1β (ng/L)

IL-6 (ng/L)

IL-10 (ng/L)

TNF-α (ng/L)

Severe VS. Mild a

0.07 (−0.05, 0.20)

25.70 (9.99, 41.41)

1.42 (0.31, 2.54)

0.28 (−2.41, 2.97)

Critical VS. Mild a

0.15 (0.01, 0.30)

56.90 (36.29, 77.52)

3.93 (2.23, 5.63)

−0.11 (−3.49, 3.26)

Critical VS. Severe a

0.08 (−0.10, 0.26)

31.21 (10.59, 51.82)

2.51 (0.54, 4.47)

−0.40 (−3.79, 3.00)

Inconsistency P-value

0.545

0.408

0.510

0.993

  1. aWhen comparing, the groups in the later positions were taken as the reference
  2. Abbreviations: IL interleukin, TNF tumor necrosis factor